Gastric and Small Bowel Tumors

L. Mark Knab, Anthony Yang

Research output: Contribution to journalReview articlepeer-review

Abstract

The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalCancer treatment and research
Volume168
DOIs
StatePublished - Jan 1 2016

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Gastric and Small Bowel Tumors'. Together they form a unique fingerprint.

Cite this